CRISPR Therapeutics (CRSP) Stock Price Target 2026

The average analyst price target for CRISPR Therapeutics is $71.74, 48.5% above the current price. Of 24 analysts, 13 rate it Buy, 10 Hold and 1 Sell. Targets range from $32 to $120. The latest change came on Nov 4, 2026, when Citigroup raised its price target on CRISPR Therapeutics from $88 to $90 and kept a Buy rating.